HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

miR-24 Alleviates MI/RI by Blocking the S100A8/TLR4/MyD88/NF-kB Pathway.

AbstractABSTRACT:
Although inflammation plays an important role in myocardial ischemia/reperfusion injury (MI/RI), an anti-inflammatory treatment with a single target has little clinical efficacy because of the multifactorial disorders involved in MI/RI. MicroRNAs (miR-24) can achieve multitarget regulation in several diseases, suggesting that this factor may have ideal effects on alleviation of MI/RI. In the present study, bioinformatics method was used to screen potential therapeutic targets of miR-24 associated with MI/RI. Three days before ischemia/reperfusion surgery, rats in the ischemia/reperfusion, miR-24, and adenovirus-negative control groups were injected with saline, miR-24, and adenovirus-negative control (0.1 mL of 5 × 109 PFU/mL), respectively. Myocardial enzymes, myocardial infarct size, cardiac function, and the possible molecular mechanism were subsequently analyzed. In contrast to the level of S100A8, the level of miR-24 in myocardial tissue was significantly reduced after 30 minutes of ischemia followed by reperfusion for 2 hours. Overexpression of miR-24 reduced the myocardial infarction area and improved the heart function of rats 3 days after MI/RI. Moreover, miR-24 inhibited infiltration of inflammatory cells in the peri-infarction area and decreased creatine kinase myocardial band and lactate dehydrogenase release. Interestingly, miR-24 upregulation reduced S100A8 expression, followed by inhibition of toll-like receptor 4/MyD-88/nuclear factor-k-gene binding signaling activation. In conclusion, miR-24 can alleviate MI/RI via inactivation of the S100A8/toll-like receptor 4/MyD-88/nuclear factor-k-gene binding signaling pathway.
AuthorsJian Yang, Zujin Xiang, Jing Zhang, Jun Yang, Yuhong Zhai, Zhixing Fan, Huibo Wang, Jingyi Wu, Yifan Huang, Mengting Xiong, Cong Ma
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 78 Issue 6 Pg. 847-857 (12 01 2021) ISSN: 1533-4023 [Electronic] United States
PMID34581696 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Chemical References
  • Calgranulin A
  • MIRN24 microRNA, rat
  • MicroRNAs
  • Myd88 protein, rat
  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • Tlr4 protein, rat
  • Toll-Like Receptor 4
Topics
  • Animals
  • Calgranulin A (genetics, metabolism)
  • Disease Models, Animal
  • Male
  • MicroRNAs (genetics, metabolism)
  • Myeloid Differentiation Factor 88 (metabolism)
  • Myocardial Infarction (genetics, metabolism, pathology, prevention & control)
  • Myocardial Reperfusion Injury (genetics, metabolism, pathology, prevention & control)
  • Myocardium (metabolism, pathology)
  • NF-kappa B (metabolism)
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Toll-Like Receptor 4 (metabolism)
  • Ventricular Function, Left

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: